Navigation Links
Hospital rankings for heart failure readmissions unaffected by patient's socioeconomic status

A new report by Icahn School of Medicine at Mount Sinai, published in the journal Circulation: Cardiovascular Quality and Outcomes, shows the socioeconomic status of congestive heart failure patients does not influence hospital rankings for heart failure readmissions.

In the study, researchers assessed whether adding a standard measure for indicating the socioeconomic status of heart failure patients could alter the expected 30-day heart failure hospital risk standardized readmission rate (RSRR) among New York City hospitals. For each patient a standard socioeconomic index score was used by the researchers based on his or her zip codes average income and educational level.

While research results show heart failure patients with a higher socioeconomic status were less likely to be readmitted, the overall impact of socioeconomic status on heart failure readmission rates was very minimal. The study also concludes that inclusion of a socioeconomic measure does not impact a hospital's RSRR profiling based on 30-day readmission.

"Our study results were unexpected and show our accounting for possible social risks of congestive heart failure patients does not alter the hospital rankings for heart failure readmission rates," says Alex Blum, MD, MPH, lead study author from the Department of Health Evidence and Policy at Icahn School of Medicine at Mount Sinai and the National Institutes of Health. "Using a standard measure for a patients' socioeconomic status, did not impact hospital-level rankings and 30-day congestive heart failure patient's readmission."

The study examined data of heart failure patient hospitalizations at 48 New York City hospitals for 17,767 Medicare patients aged 65 years and older who had a combined 25,962 hospitalizations between 2006 and 2009.

Congestive heart failure is the most common cause of hospital readmission in the United States for patients age 65 years or older and in the Medicare program. The costly condition imposes a large burden on the U.S. healthcare system with an estimated cost of $15 billion each year.

Experts have estimated that $12 billion of the annual costs of caring for congestive heart failure could be prevented through prevention of readmissions. To assess hospital performance in this area, the Centers for Medicare & Medicaid Services (CMS), developed a model to create hospital-level 30-day congestive heart failure RSRR. As a result, hospitals with excessive, or more than expected readmission rates, have begun to lose a percentage of their Medicare reimbursements.

However, according to researchers the current CMS model only accounts for patient age, gender, and co-morbid health conditions and lacks measures of socioeconomic or social status. "There are too few variables in Medicare data to adequately capture a heart failure patient's social risks and therefore insufficient data available to researchers and policymakers to determine if current payment and reimbursement healthcare reform policies hurt hospitals that care for the more socially disadvantaged," says Dr. Blum of Mount Sinai.

According to researchers, better measures may be needed to assess the true impact of socioeconomic risk factors on hospital profiling based on 30-day congestive heart failure readmissions, and to fully explore the impact of CMS's new healthcare reform policies on hospital profiling.


Contact: Lauren Woods
The Mount Sinai Hospital / Mount Sinai School of Medicine

Related medicine news :

1. Mayo Clinic study identifies strategies that reduce early hospital readmissions
2. Hospitals ranked on complications after hip and knee replacement surgeries
3. Beaumont Childrens Hospital awarded $20,000 from CureSearch for cancer research
4. Hospitals recover from recession, some financial issues remain
5. New expert guidelines aim to focus hospitals infectious diarrhea prevention efforts
6. Test that measures everyday task performance is a good predictor of hospital readmission
7. Electronic tool helps reduce drug errors among hospitalized children
8. Study shows link between sleep apnea and hospital maternal deaths
9. St. Jude Childrens Research Hospital scientist elected to National Academy of Sciences
10. RI Hospital: Medicare patients with dementia 20 percent more likely to be readmitted
11. Major lung resection safer than ever, especially at the busiest hospitals
Post Your Comments:
Related Image:
Hospital rankings for heart failure readmissions unaffected by patient's socioeconomic status
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: